Penn State
Penn State Portable Molecular COVID-19 Test Aims to Fill Gap Between Antigen and Molecular Tests
Premium
The test consists of two components, a microfluidic cartridge and a handheld analyzer, and returns results in 45 minutes or less.
Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
SeqOne Looks to Support NGS-Based COVID-19 Testing to Accelerate Pandemic Screening, Tracing
French startup SeqOne has adapted its sequencing data-analysis platform to support a new method for high-throughput processing of coronavirus tests in its home country.
High-Throughput Diagnostic COVID-19 Sequencing Assays May Enable Large-Scale Testing
Assays like SwabSeq, Dx-Seq, and LAMP-Seq promise to analyze tens to hundreds of thousands of samples in parallel but might be constrained by sample availability.
Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases
The company hopes to develop saliva-based RNA assays for concussion, Parkinson's disease and autism using biomarkers discovered by its two academic partners.